EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Tamoxifen-induced neutropenia and leukopenia in a breast cancer patient: a case report and literature review

Cheng Liu, Fadong Xu, Qinglai Liu

Frontiers in Oncology · 01.04.2026 · 16

DOI: 10.3389/fonc.2026.1691480 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 01.04.2026. Verfasst von Cheng Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Liaocheng Maternity and Child Health Care Hospital, Liaocheng, Shandong, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tamoxifen is a cornerstone of endocrine therapy for hormone receptor-positive breast cancer. While its common side effects are well-documented, severe hematological toxicities such as neutropenia and leukopenia are extremely rare. Case presentation We report a case of a 37-year-old premenopausal woman with hormone receptor-positive breast cancer who developed neutropenia and leukopenia three months after initiating adjuvant tamoxifen (20 mg/day). Despite transient improvements with supportive therapies (leucogen tablets and Compound Ejiao Jiang), cytopenias persisted. Tamoxifen was discontinued and switched to ovarian function suppression (leuprolide) plus an aromatase inhibitor (exemestane). Within four weeks, neutrophil and leukocyte counts normalized and remained stable over six months of follow-up.

Conclusion

This case highlights the importance of recognizing tamoxifen-induced hematological toxicity. Regular blood count monitoring is essential, and in premenopausal women intolerant to tamoxifen, switching to ovarian function suppression plus an aromatase inhibitor is a safe and effective alternative.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactionagranulocytosisbreast neoplasm cancerendocrine therapyleukopeniatamoxifen

Autor:innen und Institutionen

  • Department of Breast Surgery, Liaocheng Maternity and Child Health Care Hospital, Liaocheng, Shandong, China.

Zitieren

APA

Liu, C., Xu, F., & Liu, Q. (2026). Tamoxifen-induced neutropenia and leukopenia in a breast cancer patient: a case report and literature review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1691480

Vancouver

Liu C, Xu F, Liu Q. Tamoxifen-induced neutropenia and leukopenia in a breast cancer patient: a case report and literature review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1691480

BibTeX
@article{Liu2026,
  author = {Liu, Cheng and Xu, Fadong and Liu, Qinglai},
  title = {Tamoxifen-induced neutropenia and leukopenia in a breast cancer patient: a case report and literature review},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1691480}
}
Kostenlos starten →